Skip to content
  • Diet & Nutrition
  • Lifestyle & Wellbeing
  • News & Research
  • Treatment & Management
  • Patient Narratives
  • Glycaemic Index
  • Carbohydrate Counting
Quest Diabetes
Quest Diabetes
  • Diet & Nutrition
  • Lifestyle & Wellbeing
  • News & Research
  • Treatment & Management
  • Patient Narratives
  • Glycaemic Index
  • Carbohydrate Counting
Quest Diabetes
  • News & Research

Persistent numbness in extremities may signal underlying neurological issues

Brief episodes of numbness are common, but ongoing or unexplained sensations could indicate serious health conditions requiring medical assessment, from nerve damage to diabetes-related complications. Numbness and tingling in the hands, feet, arms or legs is often brief and harmless,…

  • apxadmin
  • August 18, 2026
  • News & Research

Genprex advances diabetes gene therapy programme with new manufacturing collaborations

Genprex moves closer to clinical testing of its diabetes gene therapy through a new manufacturing partnership, amid ongoing efforts to build its pipeline despite high investor caution. Genprex has moved a step closer to advancing its diabetes gene therapy programme…

  • apxadmin
  • August 18, 2026
  • Glycaemic Index

GLP-1 medicines offer new hope for building healthier habits amid obesity and addiction concerns

Primary care physician Lucy McBride emphasises that GLP-1 drugs are most effective when integrated into comprehensive treatment plans, extending their promise beyond weight loss to potentially reduce alcohol cravings and support behavioural change. GLP-1 medicines are best understood as part…

  • apxadmin
  • August 18, 2026
  • Patient Narratives

Experts dismiss detox diets as unnecessary and potentially risky for healthy individuals

Medical authorities warn that the body’s natural systems are sufficient for waste removal, challenging the health claims of commercial detox programmes and highlighting safety concerns associated with unnecessary cleansing practices. Specialists say the body already has built-in systems for removing…

  • apxadmin
  • August 18, 2026
  • News & Research

Amylyx shares soar as late-stage trial shows promising results for avexitide

Amylyx Pharmaceuticals’ stock jumped 21% in pre-market trading following positive Phase 3 trial results for its experimental drug avexitide, signalling potential breakthrough in post-bariatric hypoglycaemia treatment. Amylyx Pharmaceuticals shares jumped in pre-market trading on Tuesday after the company said avexitide,…

  • apxadmin
  • August 18, 2026
  • News & Research

Swedish study links acromegaly-associated diabetes to increased cardiovascular risks

A Swedish nationwide study reveals that patients with acromegaly-related diabetes face a significantly higher cardiovascular burden than those with type 2 diabetes alone, highlighting the need for targeted risk management. People with acromegaly-associated diabetes appear to face a heavier cardiovascular…

  • apxadmin
  • August 18, 2026
  • News & Research

Researchers defend dosing choices in semaglutide study on diabetic osteoblasts

Researchers clarify their dosing strategies in a study examining semaglutide’s effects on osteoblast ferroptosis, addressing criticisms over dosage relevance and pathway analysis, and emphasising its mechanistic focus. Researchers behind a study on semaglutide and diabetic periodontitis have pushed back against…

  • apxadmin
  • August 18, 2026
  • Glycaemic Index

Turkish health official warns of rising health risks linked to starch-based sugar consumption

Turkish health authorities highlight the growing health concerns associated with high-fructose corn syrup and starch-based sugars, urging for better labels and reduced intake, especially among children and at-risk groups. Turkish health official İlhan Satman has warned that heavy consumption of…

  • apxadmin
  • August 18, 2026
  • Treatment & Management

Inflammation markers SII and SIRI show potential for early gestational diabetes risk detection, but evidence remains inconclusive

Two inflammation-based blood markers, SII and SIRI, may help identify women at higher risk of gestational diabetes, though current evidence is limited and more research is needed before they can be used routinely in clinical practice. New research suggests two…

  • apxadmin
  • August 18, 2026
  • News & Research

Diabetic kidney disease market set for rapid growth driven by AI and personalised therapies

The diabetic kidney disease sector is projected to reach $3.76 billion by 2030, driven by advancements in personalised medicine, early screening, and artificial intelligence, reshaping preventative care practices. The diabetic kidney disease market is expected to keep expanding steadily through…

  • apxadmin
  • August 18, 2026
Prev
1 … 36 37 38 39 40 41 42 … 83
Next

Search

No results

Posts

Not all porridge is equally healthy: the grains that can impact blood sugar more than you think

August 18, 2026

Emerging natural sweeteners challenge sugar with new health and taste dynamics

August 3, 2026

Summer health risks for diabetics highlight importance of infection prevention and hydration

August 5, 2026

Russian expert highlights overlooked risk of diabetes in lean and 'skinny fat' individuals

August 11, 2026

Making pasta diabetic-friendly: innovative approaches to healthy eating

July 31, 2026

Trending now

Adding legumes and proper rice preparation can improve blood sugar control, experts say
New insights suggest apples and pears are equally beneficial for blood sugar control when eaten whole
New genetic insights suggest type 1 diabetes may comprise distinct disease groups
New wearable device highlights importance of ketone monitoring in diabetes management

Copyright © 2026 - QuestDiabetes.com

Disclaimer | Terms & Conditions | Privacy Policy